DEFERASIROX News
DEFERASIROX currently has 0 news articles, with 12 predicted indications.
This page combines the AI-predicted indications for DEFERASIROX with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (12):
- hereditary persistence of fetal hemoglobin (99.0%)
- beta-thalassemia intermedia (99.0%)
- dominant beta-thalassemia (99.0%)
- beta-thalassemia and related diseases (99.0%)
- beta thalassemia (99.0%)
- beta-thalassemia HBB/LCRB (99.0%)
- hemoglobinopathy (99.0%)
- HIV infectious disease (99.4%)
- chronic hepatitis C virus infection (99.4%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.2%)
- obsolete familial combined hyperlipidemia (99.2%)
- dermatofibrosarcoma protuberans (99.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.